{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T19:15:21Z","timestamp":1769022921001,"version":"3.49.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","jiac-j.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.jiac.2024.08.009","type":"journal-article","created":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T15:50:48Z","timestamp":1723737048000},"page":"102494","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Cryptococcal prostatitis in an immunocompromised patient with tocilizumab and glucocorticoid therapy: A case report"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-9020-6118","authenticated-orcid":false,"given":"Kohei","family":"Oguni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinnosuke","family":"Fukushima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5086-1891","authenticated-orcid":false,"given":"Hideharu","family":"Hagiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuhito","family":"Suyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6116-543X","authenticated-orcid":false,"given":"Takehiro","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6981-3443","authenticated-orcid":false,"given":"Yoshia","family":"Miyawaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sawako","family":"Ono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Iio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7014-9095","authenticated-orcid":false,"given":"Fumio","family":"Otsuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2024.08.009_bib1","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1099\/mic.0.000973","article-title":"Microbe Profile: cryptococcus neoformans species complex","volume":"166","author":"Bahn","year":"2020","journal-title":"Microbiology (Read)"},{"key":"10.1016\/j.jiac.2024.08.009_bib2","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nrmicro.2015.6","article-title":"Cryptococcus: from environmental saprophyte to global pathogen","volume":"14","author":"May","year":"2016","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.jiac.2024.08.009_bib3","author":"Organization"},{"key":"10.1016\/j.jiac.2024.08.009_bib4","first-page":"493","article-title":"Cryptococcosis","volume":"35","author":"Gushiken","year":"2021","journal-title":"Infect Dis Clin"},{"key":"10.1016\/j.jiac.2024.08.009_bib5","doi-asserted-by":"crossref","first-page":"125","DOI":"10.7326\/0003-4819-111-2-125","article-title":"Persistent Cryptococcus neoformans infection of the prostate after successful treatment of meningitis. California Collaborative Treatment Group","volume":"111","author":"Larsen","year":"1989","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jiac.2024.08.009_bib6","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1007\/s40265-017-0829-7","article-title":"Tocilizumab: a review in rheumatoid arthritis","volume":"77","author":"Scott","year":"2017","journal-title":"Drugs"},{"issue":"8","key":"10.1016\/j.jiac.2024.08.009_bib7","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a028456","article-title":"Interleukin (IL-6) immunotherapy","volume":"10","author":"Tanaka","year":"2018","journal-title":"Cold Spring Harbor Perspect Biol"},{"key":"10.1016\/j.jiac.2024.08.009_bib8","first-page":"Cd013484","article-title":"Tocilizumab for giant cell arteritis","volume":"8","author":"Antonio","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jiac.2024.08.009_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.825749","article-title":"Tocilizumab and COVID-19: timing of administration and efficacy","volume":"13","author":"Abidi","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jiac.2024.08.009_bib10","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/myc.13476","article-title":"Cryptococcosis among hospitalised patients with COVID-19: a multicentre research network study","volume":"65","author":"Chastain","year":"2022","journal-title":"Mycoses"},{"key":"10.1016\/j.jiac.2024.08.009_bib11","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1002\/pros.24034","article-title":"Fungal prostatitis due to endemic mycoses and Cryptococcus: a multicenter case series","volume":"80","author":"Epstein","year":"2020","journal-title":"Prostate"},{"key":"10.1016\/j.jiac.2024.08.009_bib12","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.biopha.2017.08.016","article-title":"Comprehensive overview of prostatitis","volume":"94","author":"Khan","year":"2017","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jiac.2024.08.009_bib13","doi-asserted-by":"crossref","first-page":"e153","DOI":"10.1016\/j.jinf.2004.12.005","article-title":"Primary cryptococcal prostatitis and correlation with serum prostate specific antigen in a renal transplant recipient","volume":"51","author":"Siddiqui","year":"2005","journal-title":"J Infect"},{"issue":"23","key":"10.1016\/j.jiac.2024.08.009_bib14","first-page":"731","article-title":"Global guideline for the diagnosis and management of cryptococcosis: an initiative of the ECMM and ISHAM in cooperation with the ASM","volume":"S1473\u20133099","author":"Chang","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jiac.2024.08.009_bib15","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/j.1442-2042.2006.01377.x","article-title":"Granulomatous cryptococcal prostatitis diagnosed by transrectal biopsy","volume":"13","author":"Seo","year":"2006","journal-title":"Int J Urol"},{"key":"10.1016\/j.jiac.2024.08.009_bib16","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.12659\/AJCR.905528","article-title":"Incidental finding of cryptococcus on prostate biopsy for prostate adenocarcinoma following cardiac transplant: case report and review of the literature","volume":"18","author":"Shah","year":"2017","journal-title":"Am J Case Rep"},{"key":"10.1016\/j.jiac.2024.08.009_bib17","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1128\/AAC.39.2.553","article-title":"Fluconazole penetration into the human prostate","volume":"39","author":"Finley","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2024.08.009_bib18","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/jac\/41.3.423","article-title":"Fluconazole penetration into the prostatic fluid of patients with AIDS-associated cryptococcal meningitis","volume":"41","author":"Luzzati","year":"1998","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2024.08.009_bib19","article-title":"Unintended consequences: risk of opportunistic infections associated with long-term glucocorticoid therapies in adults","author":"Chastain","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2024.08.009_bib20","doi-asserted-by":"crossref","DOI":"10.1111\/myc.13709","article-title":"Glucocorticoids as a risk factor for infection and adverse outcomes in non-HIV and non-transplant patients with cryptococcal meningitis","volume":"67","author":"Kim","year":"2024","journal-title":"Mycoses"},{"key":"10.1016\/j.jiac.2024.08.009_bib21","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jiac.2017.09.009","article-title":"Disseminated cryptococcosis in a patient taking tocilizumab for Castleman's disease","volume":"24","author":"Nishioka","year":"2018","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jiac.2024.08.009_bib22","doi-asserted-by":"crossref","first-page":"R141","DOI":"10.1186\/ar3455","article-title":"Integrated safety in tocilizumab clinical trials","volume":"13","author":"Schiff","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jiac.2024.08.009_bib23","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s11046-023-00814-1","article-title":"Trends in the incidence of disseminated cryptococcosis in Japan: a nationwide observational study, 2015-2021","volume":"189","author":"Akazawa","year":"2024","journal-title":"Mycopathologia"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X24002204?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X24002204?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T11:43:12Z","timestamp":1736768592000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X24002204"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S1341321X24002204"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2024.08.009","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cryptococcal prostatitis in an immunocompromised patient with tocilizumab and glucocorticoid therapy: A case report","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2024.08.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102494"}}